The association of PD-L1 expression with the efficacy of anti-PD-1/PD-L1 immunotherapy and survival of non-small cell lung cancer patients: a meta-analysis of randomized controlled trials

BACKGROUND: We conducted a meta-analysis to evaluate the efficacy of anti-programmed cell death 1 (PD-1)/programmed cell death ligand 1 (PD-L1) monotherapy or immunotherapy combined with chemotherapy and further estimated the value of PD-L1 expression in predicting the response from anti-PD-1/PD-L1...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Transl Lung Cancer Res
Glavni autori: Xu, Yangyang, Wan, Bing, Chen, Xi, Zhan, Ping, Zhao, Yuan, Zhang, Tianli, Liu, Hongbing, Afzal, Muhammad Zubair, Dermime, Said, Hochwald, Steven N., Hofman, Paul, Borghaei, Hossein, Lin, Dang, Lv, Tangfeng, Song, Yong
Format: Artigo
Jezik:Inglês
Izdano: AME Publishing Company 2019
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6749123/
https://ncbi.nlm.nih.gov/pubmed/31555516
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2019.08.09
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items